News

There is a new medicine that has surpassed Bluebird Bio as the costliest in the world. Hemgenix, a haemophilia B gene therapy developed by CSL Behring and uniQure, debuted as the first gene therapy authorised for the uncommon illness following...

The identification and detection of the β-lactams cephapirin and ceftiofur in cleaning solutions of the production reactors have been validated using ultra-performance liquid chromatography with a triple quadrupole mass spectrometry, or UHPLC-MS/MS, according to a paper published in the...

As the world's pharmacy, India had a 138% growth in pharmaceutical exports from April through October 2022–23 compared to the same time in 2013–14. Since April through October, India's pharmaceutical exports have increased by 138%, rising from Rs 37,987.68...

In an effort to advance personalised cancer treatment, researchers have shown that biomarkers alone cannot predict which patients will benefit most from immunotherapy. Clinicians should comprehend how immune cells and tumours are functioning within a patient rather than relying solely...

To support innovative approaches for the development, manufacture, and quality control (QC) of medicines, along with new technologies, digitalization, novel materials, and novel devices for patients in the European Union, the European Medicines Agency (EMA) formed the Quality Innovation...

RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) technology platform company incubated by CBC Group, a healthcare-dedicated asset management firm headquartered in Singapore, and the Agency for Science, Technology and Research (A*STAR) announced the signing of a master research collaboration agreement...

Continuing the winning streak of CPhI & P-MEC India, Informa Markets, the leading international B2B events group is once again back with its 15th edition in an evolved hybrid format to be held from 29th November to 1st December...